Company location
Tokyo, Japan
TAKEDA PHARMACEUTICAL CO LTD has filed 676 SEC EDGAR filings since 05 Mar 2007

SEC filing history

Showing 301-325 of 662 matching filings.

Per page
25
Current page
13
6-K File 001-38757

FORM 6-K

Filing date
10 Feb 2023
Reporting date
10 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

FORM 6-K

Filing date
09 Feb 2023
Reporting date
09 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90834

SC 13G/A filing

Filing date
07 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

FORM 6-K

Filing date
07 Feb 2023
Reporting date
07 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

SC 13G/A filing

Filing date
03 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

SC 13G/A

Filing date
03 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90834

AMENDMENT NO. 2

Filing date
03 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

FORM 6-K

Filing date
02 Feb 2023
Reporting date
02 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

FORM 6-K

Filing date
10 Jan 2023
Reporting date
10 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

FORM 6-K

Filing date
05 Jan 2023
Reporting date
05 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

FORM 6-K

Filing date
21 Dec 2022
Reporting date
21 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

FORM 6-K

Filing date
13 Dec 2022
Reporting date
13 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

FORM 6-K

Filing date
08 Dec 2022
Reporting date
08 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-41365

FORM 4

Filing date
01 Dec 2022
Reporting date
30 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

FORM 6-K

Filing date
30 Nov 2022
Reporting date
30 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

FORM 6-K

Filing date
04 Nov 2022
Reporting date
04 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

FORM 6-K

Filing date
27 Oct 2022
Reporting date
27 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

FORM 6-K

Filing date
14 Oct 2022
Reporting date
14 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

FORM 6-K

Filing date
04 Oct 2022
Reporting date
04 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

FORM 6-K

Filing date
23 Aug 2022
Reporting date
23 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

SC 13G/A

Filing date
05 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

FORM 6-K

Filing date
04 Aug 2022
Reporting date
04 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

FORM 6-K

Filing date
28 Jul 2022
Reporting date
28 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

FORM 6-K

Filing date
11 Jul 2022
Reporting date
11 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-38085

FORM 4

Filing date
06 Jul 2022
Reporting date
01 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .